The vector of anti-CD19×HER2 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD19 and HER2. The T cells are genetically modified through transduction with a lentiviral vector expressing scFvs of an anti-CD19 antibody and an anti-HER2 antibody linked to CD3ζ signaling domains. And the vector product was designed for the treatment of CD19+/HER2+ cancers.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-LC233||Anti-CD19 (S2) h(CD28-CD3ζ) CAR, pCDCAR1|
|CAR-NK-1-M328-2||Anti-CD19 scFv h(CD28) CARNK, pCDCAR1|
|CAR-MZ129||Anti-CD19 (SJ25C1) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-LC151||Anti-CD19 (105975) h(41BB-CD3ζ) CAR, pCDCAR1|
|CAR-T-2-L332-2G||Anti-CD19 scFv h(CD28-FcεRIγ) CART, pCDCAR1|
|CAR-LC279||Anti-CD19 (FMC63) h(41BB-CD3ζ, K4/E4) Conditional CAR, pCDCAR1|
|CAR-LC163||Anti-CD19 (h119a) h(CD28-CD3ζ) CAR, pCDCAR1|
|VP-CAR-LC629||Lenti-CD19 CAR (scFv-41BB-CD3ζ, 104878) Viral Particle|
|CAR-LC012||Anti-CD19 (47G4) h(CD28-CD27-CD3ζ) CAR, pCDCAR1|
|CAR-MZ052||Anti-CD19 scFv h(41BB-CD28-CD3ζ) CAR, pCDCAR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved